Platelets and the antiphospholipid syndrome

Lupus

Volumn 17, Issue 10, 2008, Pages 888-894

  Urbanus, R T ^a   Derksen, R H W M ^a   de Groot, Philip G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DINORTHROMBOXANE B2; ACETYLSALICYLIC ACID; BETA THROMBOGLOBULIN; BETA2 GLYCOPROTEIN 1 ANTIBODY; CLOPIDOGREL; COLLAGEN; GLYCOPROTEIN IB ALPHA; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PHOSPHOLIPID ANTIBODY; THROMBIN; THROMBOXANE A2; TOLL LIKE RECEPTOR 4; VON WILLEBRAND FACTOR; BETA2 GLYCOPROTEIN 1;

ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; BLEEDING TIME; BLOOD VESSEL INJURY; HUMAN; NONHUMAN; PATHOGENESIS; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW; SHEAR STRESS; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOEMBOLISM; VEIN THROMBOSIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; THROMBOSIS;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; HUMANS; PLATELET ACTIVATION; THROMBOSIS;

EID: 58449098695     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203308096344     Document Type: Review

References (68)

1. Sixma JJ Wester J. The hemostatic plug. Semin Hematol 1977;14:265-299.
2. Jackson SP. The growing complexity of platelet aggregation. Blood 2007;109:5087-5095.
3. Jones CI Garner SF Angenent W. Mapping the platelet profile for functional genomic studies and demonstration of the effect size of the GP6 locus. J Thromb Haemost 2007;5:1756-1765.
4. Goldsmith HL Turitto VT. Rheological aspects of thrombosis and haemostasis: Basic principles and applications. ICTH-Report-Subcommittee on Rheology of the International Committee on Thrombosis and Haemostasis. Thromb Haemost 1986;55:415-435.
5. De Groot PG Sixma JJ. Perfusion chambers. In: AD Michelson 13;, (ed), Platelets. Academic Press; 2002. p. 347-356.
6. Ruggeri ZM Mendolicchio GL. Adhesion mechanisms in platelet function. Circ Res 2007;100:1673-1685.
7. Turitto VT Weiss HJ Baumgartner HR. Decreased platelet adhesion on vessel segments in von Willebrand's disease: A defect in initial platelet attachment. J Lab Clin Med 1983;102:551-564.
8. Farndale RW Sixma JJ Barnes MJ de Groot PG. The role of collagen in thrombosis and hemostasis. J Thromb Haemost 2004;2:561-573.
9. Huizinga EG Tsuji S Romijn RA. Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain. Science 2002;297:1176-1179.
10. Savage B Saldivar E Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996;84:289-297.
11. Arai M Yamamoto N Moroi M Akamatsu N Fukutake K Tanoue K. Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency. Br J Haematol 1995;89:124-130.
12. Beumer S IJsseldijk MJ de Groot PG Sixma JJ. Platelet adhesion to fibronectin in flow: Dependence on surface concentration and shear rate, role of platelet membrane glycoproteins GP IIb/IIIa and VLA-5, and inhibition by heparin. Blood 1994;84:3724-3733.
13. Weiss HJ Turitto VT Baumgartner HR. Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules. Blood 1986;67:322-330.
14. Gruner S Prostredna M Schulte V. Multiple integrin-ligand interactions synergize in shear-resistant platelet adhesion at sites of arterial injury in vivo. Blood 2003;102:4021-4027.
15. Savage B Cattaneo M Ruggeri ZM. Mechanisms of platelet aggregation. Curr Opin Hematol 2001;8:270-276.
16. Jackson SP Nesbitt WS Kulkarni S. Signaling events underlying thrombus formation. J Thromb Haemost 2003;1:1602-1612.
17. Weiss HJ Turitto VT Baumgartner HR. Further evidence that glycoprotein IIb-IIIa mediates platelet spreading on subendothelium. Thromb Haemost 1991;65:202-205.
18. Kulkarni S Dopheide SM Yap CL. A revised model of platelet aggregation. J Clin Invest 2000;105:783-791.
19. Ruggeri ZM. Old concepts and new developments in the study of platelet aggregation. J Clin Invest 2000;105:699-701.
20. Remijn JA Wu YP Jeninga EH. Role of ADP receptor P2Y(12) in platelet adhesion and thrombus formation in flowing blood. Arterioscler Thromb Vasc Biol 2002;22:686-691.
21. Barstad RM Orvim U Hamers MJ Tjønnfjord GE Brosstad FR Sakariassen KS. Reduced effect of aspirin on thrombus formation at high shear and disturbed laminar blood flow. Thromb Haemost 1996;75:827-832.
22. Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost 2001;86:222-232.
23. Roald HE Orvim U Bakken IJ Barstad RM Kierulf P Sakariassen KS. Modulation of thrombotic responses in moderately stenosed arteries by cigarette smoking and aspirin ingestion. Arterioscler Thromb 1994;14:617-621.
24. Clemetson KJ. A short history of platelet glycoprotein Ib complex. Thromb Haemost 2007;98:63-68.
25. Adams TE Huntington JA. Thrombin-cofactor interactions: Structural insights into regulatory mechanisms. Arterioscler Thromb Vasc Biol 2006;26:1738-1745.
26. Patrono C Garcia Rodriguez LA Landolfi R Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005;353:2373-2383.
27. Forastiero R Martinuzzo M Carreras LO Maclouf J. Anti-beta2 glycoprotein I antibodies and platelet activation in patients with antiphospholipid antibodies: Association with increased excretion of platelet-derived thromboxane urinary metabolites. Thromb Haemost 1998;79:42-45.
28. Galli M Cortelazzo S Viero P Finazzi G de Gaetano G Barbui T. Interaction between platelets and lupus anticoagulant. Eur J Haematol 1988;41:88-94.
29. Campbell AL Pierangeli SS Wellhausen S Harris EN. Comparison of the effects of anticardiolipin antibodies from patients with the antiphospholipid syndrome and with syphilis on platelet activation and aggregation. Thromb Haemost 1995;73:529-534.
30. Martinuzzo ME Maclouf J Carreras LO Levy-Toledano S. Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation. Thromb Haemost 1993;70:667-671.
31. Espinola RG Pierangeli SS Gharavi AE Harris EN. Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies. Thromb Haemost 2002;87:518-522.
32. Orlando E Cortelazzo S Marchetti M Sanfratello R Barbui T. Prolonged bleeding time in patients with lupus anticoagulant. Thromb Haemost 1992;68:495-499.
33. Urbanus RT de Laat HB de Groot PG Derksen RH. Prolonged bleeding time and lupus anticoagulant: A second paradox in the antiphospholipid syndrome. Arthritis Rheum 2004;50:3605-3609.
34. Martinuzzo ME Maclouf J Carreras LO Levy-Toledano S. Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation. Thromb Haemost 1993;70:667-671.
35. Lutters BC Meijers JC Derksen RH Arnout J de Groot PG. Dimers of beta 2-glycoprotein I mimic the in vitro effects of beta 2-glycoprotein I-anti-beta 2-glycoprotein I antibody complexes. J Biol Chem 2001;276:3060-3067.
36. Jankowski M Vreys I Wittevrongel C. Thrombogenicity of beta 2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster. Blood 2003;101:157-162.
37. Lutters BC Derksen RH Tekelenburg WL Lenting PJ Arnout J de Groot PG. Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'. J Biol Chem 2003;278:33831-33838.
38. Riddell DR Vinogradov DV Stannard AK Chadwick N Owen JS. Identification and characterization of LRP8 (apoER2) in human blood platelets. J Lipid Res 1999;40:1925-1930.
39. Pennings MT van Lummel M Derksen RH. Interaction of beta2-glycoprotein I with members of the low density lipoprotein receptor family. J Thromb Haemost 2006;4:1680-1690.
40. Korporaal SJ Relou IA van Eck M. Binding of low density lipoprotein to platelet apolipoprotein E receptor 2' results in phosphorylation of p38MAPK. J Biol Chem 2004;279:52526-52534.
41. Shen GQ Li L Girelli D. An LRP8 variant is associated with familial and premature coronary artery disease and myocardial infarction. Am J Hum Genet 2007;81:780-791.
42. Pennings MT Derksen RH Urbanus RT Tekelenburg WL 13; Hemrika W de Groot PG. Platelets express three different splice variants of ApoER2 that are all involved in signaling. J Thromb Haemost 2007;5:1538-1544.
43. Herz J Strickland DK. LRP: A multifunctional scavenger and signaling receptor. J Clin Invest 2001;108:779-784.
44. Lillis AP Mikhailenko I Strickland DK. Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability. J Thromb Haemost 2005;3:1884-1893.
45. Wang L Wang X Laird N Zuckerman B Stubblefield P Xu X. Polymorphism in maternal LRP8 gene is associated with fetal growth. Am J Hum Genet 2006;78:770-777.
46. Ma SL Ng HK Baum L. Low-density lipoprotein receptor-related protein 8 (apolipoprotein E receptor 2) gene polymorphisms in Alzheimer's disease. Neurosci Lett 2002;332:216-218.
47. Gent J Braakman I. Low-density lipoprotein receptor structure and folding. Cell Mol Life Sci 2004;61:2461-2470.
48. Van Lummel M Pennings MT Derksen RH. The binding site in {beta}2-glycoprotein I for ApoER2' on platelets is located in domain V. J Biol Chem 2005;280:36729-36736.
49. Shi T Giannakopoulos B Yan X. Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V. Arthritis Rheum 2006;54:2558-2567.
50. Pennings MT Derksen RH van Lummel M. Platelet adhesion to dimeric beta-glycoprotein I under conditions of flow is mediated by at least two receptors: Glycoprotein Ibalpha and apolipoprotein E receptor 2'. J Thromb Haemost 2007;5:369-377.
51. Raschi E Testoni C Bosisio D. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood 2003;101:3495-3500.
52. Clark SR Ma AC Tavener SA. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007;13:463-469.
53. Vega-Ostertag M Harris EN Pierangeli SS. Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin. Arthritis Rheum 2004;50:2911-2919.
54. Canobbio I Reineri S Sinigaglia F Balduini C Torti M. A role for p38 MAP kinase in platelet activation by von Willebrand factor. Thromb Haemost 2004;91:102-110.
55. Bock HH Jossin Y Liu P. Phosphatidylinositol 3-kinase interacts with the adaptor protein Dab1 in response to Reelin signaling and is required for normal cortical lamination. J Biol Chem 2003;278:38772-38779.
56. Yap CL Anderson KE Hughan SC Dopheide SM Salem HH Jackson SP. Essential role for phosphoinositide 3-kinase in shear-dependent signaling between platelet glycoprotein Ib/V/IX and integrin alpha(IIb)beta(3). Blood 2002;99:151-158.
57. Urbanus RT Pennings MT Derksen RH de Groot PG. Platelet activation by dimeric beta(2)-glycoprotein I requires signaling via both glycoprotein Ibalpha and Apolipoprotein E Receptor 2'. J Thromb Haemost 2008;6:1405-1412.
58. Mori T Takeya H Nishioka J Gabazza EC Suzuki K. beta 2-Glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface. Thromb Haemost 1996;75:49-55.
59. Shi T Iverson GM Qi JC. Beta 2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: Loss of inhibition by clipped beta 2-glycoprotein I. Proc Natl Acad Sci U S A 2004;101:3939-3944.
60. Sheng Y Reddel SW Herzog H. Impaired thrombin generation in beta 2-glycoprotein I null mice. J Biol Chem 2001;276:13817-13821.
61. Bancsi LF van der Linden I Bertina RM. Beta 2-glycoprotein I deficiency and the risk of thrombosis. Thromb Haemost 1992;67:649-653.
62. Hulstein JJ Lenting PJ de Laat B Derksen RH Fijnheer R de Groot PG. beta2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation. Blood 2007;110:1483-1491.
63. Ferrara DE Swerlick R Casper K. Fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells. J Thromb Haemost 2004;2:1558-1563.
64. Zhou H Wolberg AS Roubey RA. Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep. Blood 2004;104:2353-2358.
65. Redecha P Tilley R Tencati M. Tissue factor: A link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury. Blood 2007;110:2423-2431.
66. Girardi G Redecha P Salmon JE. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 2004;10:1222-1226.
67. Galli M Reber G de Moerloose P de Groot PG. Invitation to a debate on the serological criteria that define the antiphospholipid syndrome. J Thromb Haemost 2008;6:399-401.
68. Hasselaar P Derksen RH Blokzijl L. Risk factors for thrombosis in lupus patients. Ann Rheum Dis 1989;48:933-940.